• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

香港青少年接种 COVID-19 BNT162b2 疫苗后出现心肌炎。

Myocarditis Following COVID-19 BNT162b2 Vaccination Among Adolescents in Hong Kong.

机构信息

Department of Medicine, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.

Centre for Safe Medication Practice and Research, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong.

出版信息

JAMA Pediatr. 2022 Jun 1;176(6):612-614. doi: 10.1001/jamapediatrics.2022.0101.

DOI:10.1001/jamapediatrics.2022.0101
PMID:35212709
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9171561/
Abstract

This cohort study assesses the association between the single-dose COVID-19 BNT162b2 vaccination regimen and myocarditis risk among vaccinated adolescents in Hong Kong before and after the single-dose policy.

摘要

本队列研究评估了在香港单剂政策前后，接种 COVID-19 BNT162b2 单剂疫苗方案与接种青少年心肌炎风险之间的关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a235/9171561/3d552bda3aed/jamapediatr-e220101-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a235/9171561/3d552bda3aed/jamapediatr-e220101-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a235/9171561/3d552bda3aed/jamapediatr-e220101-g001.jpg

相似文献

1
Myocarditis Following COVID-19 BNT162b2 Vaccination Among Adolescents in Hong Kong.香港青少年接种 COVID-19 BNT162b2 疫苗后出现心肌炎。
JAMA Pediatr. 2022 Jun 1;176(6):612-614. doi: 10.1001/jamapediatrics.2022.0101.
2
Genome-wide association study of BNT162b2 vaccine-related myocarditis identifies potential predisposing functional areas in Hong Kong adolescents.香港青少年 BNT162b2 疫苗相关心肌炎的全基因组关联研究确定了潜在的易患功能区域。
BMC Genom Data. 2024 Jun 6;25(1):51. doi: 10.1186/s12863-024-01238-6.
3
Medium-term outcomes of myocarditis and pericarditis following BNT162b2 vaccination among adolescents in Hong Kong.香港青少年接种 BNT162b2 疫苗后心肌炎和心包炎的中期结果。
Emerg Microbes Infect. 2022 Dec;11(1):2466-2473. doi: 10.1080/22221751.2022.2128436.
4
Myocarditis after BNT162b2 Vaccination in Israeli Adolescents.以色列青少年接种BNT162b2疫苗后发生的心肌炎
N Engl J Med. 2022 Nov 10;387(19):1816-1817. doi: 10.1056/NEJMc2207270. Epub 2022 Oct 19.
5
Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination.香港青少年接种 Comirnaty 疫苗后心肌炎/心包炎的流行病学。
Clin Infect Dis. 2022 Sep 10;75(4):673-681. doi: 10.1093/cid/ciab989.
6
Effectiveness of BNT162b2 after extending the primary series dosing interval in children and adolescents aged 5-17.儿童和青少年 5-17 岁人群延长初级系列接种间隔时间后 BNT162b2 的有效性。
Nat Commun. 2023 Apr 3;14(1):1845. doi: 10.1038/s41467-023-37556-z.
7
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.mRNA COVID-19 疫苗接种后美国军人中的心肌炎。
JAMA Cardiol. 2021 Oct 1;6(10):1202-1206. doi: 10.1001/jamacardio.2021.2833.
8
Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination.mRNA COVID-19 疫苗接种后发生急性心肌炎的患者。
JAMA Cardiol. 2021 Oct 1;6(10):1196-1201. doi: 10.1001/jamacardio.2021.2828.
9
Myocarditis after vaccination against covid-19.接种新冠疫苗后发生的心肌炎
BMJ. 2021 Dec 16;375:n3090. doi: 10.1136/bmj.n3090.
10
Acute Myocarditis after mRNA COVID-19 Vaccine: A CorrespondenceReplyAcute Myocarditis Following mRNA COVID-19 VaccineMyocarditis after BNT162b2 mRNA Vaccine Against Covid-19 in IsraelMyocarditis after Covid-19 Vaccination in a Large Health Care OrganizationReceipt of mRNA Vaccine against Covid-19 and Myocarditis.mRNA新冠疫苗接种后急性心肌炎：一封通信回复 mRNA新冠疫苗接种后急性心肌炎 以色列BNT162b2 mRNA新冠疫苗接种后心肌炎 大型医疗保健机构中新冠疫苗接种后心肌炎 接种mRNA新冠疫苗与心肌炎
Arq Bras Cardiol. 2022 Dec 19;119(6):1006-1007. doi: 10.36660/abc.20220331.

引用本文的文献

1
The New Era of mRNA Vaccines: The Success of the COVID-19 Vaccines and the Safety Concerns in Adolescents.mRNA疫苗的新时代：新冠疫苗的成功与青少年的安全性担忧
Indian J Community Med. 2025 May-Jun;50(3):404-406. doi: 10.4103/ijcm.ijcm_544_23. Epub 2024 Nov 13.
2
SARS-CoV-2 Spike Protein and Long COVID-Part 1: Impact of Spike Protein in Pathophysiological Mechanisms of Long COVID Syndrome.严重急性呼吸综合征冠状病毒2刺突蛋白与长期新冠——第1部分：刺突蛋白在长期新冠综合征病理生理机制中的影响
Viruses. 2025 Apr 25;17(5):617. doi: 10.3390/v17050617.
3
The protective role of vitamin D in BNT162b2 vaccine-related acute myocarditis.

本文引用的文献

1
Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine : A Case-Control Study.mRNA 疫苗和灭活病毒疫苗接种后 COVID-19 相关心肌炎：一项病例对照研究。
Ann Intern Med. 2022 Mar;175(3):362-370. doi: 10.7326/M21-3700. Epub 2022 Jan 25.
2
Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination.香港青少年接种 Comirnaty 疫苗后心肌炎/心包炎的流行病学。
Clin Infect Dis. 2022 Sep 10;75(4):673-681. doi: 10.1093/cid/ciab989.
3
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age.
维生素D在BNT162b2疫苗相关急性心肌炎中的保护作用。
Front Immunol. 2025 Feb 19;16:1501609. doi: 10.3389/fimmu.2025.1501609. eCollection 2025.
4
Myocarditis and Pericarditis are Temporally Associated with BNT162b2 COVID-19 Vaccine in Adolescents: A Systematic Review and Meta-analysis.青少年心肌炎和心包炎与BNT162b2新冠疫苗存在时间关联：一项系统评价与荟萃分析
Pediatr Cardiol. 2024 Oct 15. doi: 10.1007/s00246-024-03618-2.
5
Incidence and management of the main serious adverse events reported after COVID-19 vaccination.报告的 COVID-19 疫苗接种后主要严重不良事件的发生率和处理。
Pharmacol Res Perspect. 2024 Jun;12(3):e1224. doi: 10.1002/prp2.1224.
6
Risk of carditis among adolescents after extending the interdose intervals of BNT162b2.延长BNT162b2疫苗接种间隔后青少年患心脏炎的风险
NPJ Vaccines. 2024 Feb 14;9(1):31. doi: 10.1038/s41541-023-00789-6.
7
Covid- 19 Vaccine-induced Myocarditis.新冠病毒疫苗诱导的心肌炎
J Community Hosp Intern Med Perspect. 2023 Sep 2;13(5):44-49. doi: 10.55729/2000-9666.1229. eCollection 2023.
8
Risk of Coronavirus Disease 2019 Messenger RNA Vaccination-Associated Myocarditis and Pericarditis - A Systematic Review of Population-Based Data.2019冠状病毒病信使核糖核酸疫苗接种相关心肌炎和心包炎的风险——基于人群数据的系统评价
Risk Manag Healthc Policy. 2023 Oct 9;16:2085-2099. doi: 10.2147/RMHP.S422372. eCollection 2023.
9
SARS-CoV-2 vaccines and myocarditis.SARS-CoV-2 疫苗与心肌炎。
Clin Med (Lond). 2023 Sep;23(5):495-502. doi: 10.7861/clinmed.2023-0049. Epub 2023 Sep 29.
10
Benefits v. risks of COVID-19 vaccination: an examination of vaccination policy impact on the occurrence of myocarditis and pericarditis.2019冠状病毒病疫苗接种的益处与风险：疫苗接种政策对心肌炎和心包炎发生率影响的考察
Lancet Reg Health West Pac. 2023 May 19;37:100797. doi: 10.1016/j.lanwpc.2023.100797.
5至11岁儿童中BNT162b2新冠疫苗的评估
N Engl J Med. 2022 Jan 6;386(1):35-46. doi: 10.1056/NEJMoa2116298. Epub 2021 Nov 9.
4
Myocarditis after Covid-19 Vaccination in a Large Health Care Organization.大型医疗机构中接种新冠疫苗后的心肌炎。
N Engl J Med. 2021 Dec 2;385(23):2132-2139. doi: 10.1056/NEJMoa2110737. Epub 2021 Oct 6.
5
Myocarditis and Pericarditis After Vaccination for COVID-19.接种 COVID-19 疫苗后的心肌炎和心包炎。
JAMA. 2021 Sep 28;326(12):1210-1212. doi: 10.1001/jama.2021.13443.
6
Clinical Characteristics and Transmission of COVID-19 in Children and Youths During 3 Waves of Outbreaks in Hong Kong.香港 3 波疫情中儿童和青少年 COVID-19 的临床特征和传播。
JAMA Netw Open. 2021 May 3;4(5):e218824. doi: 10.1001/jamanetworkopen.2021.8824.